EPA Delays PFAS Survey, AI BioDesign Accelerator Launches, Ultragenyx Drug Flops Stock Plummets, Climate Predictions Vindicated by Science, and more...
Published: September 4, 2026
Duration: 10:09
(0:10): EPA Delays PFAS Wastewater Survey, Sparking Debate Over Industry Influence and Public Health Risks
(1:36): AI BioDesign Accelerator Launches with $94.6M Funding to Revolutionize Biological Engineering
(3:59): Ultragenyx's Drug Failure Sparks Stock Plunge, Reassessment of Angelman Syndrome Program
(6:03): 1990 IPCC Report Vindicated: Climate Change Predictions Hindered by Political Will, Not Science
(7:44): Study Unveils ATRX's Crucial Role in DNA Replication and Telomere Maintenance
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: WSOC TV
(1:36): AI BioDesign Accelerator Launches with $94.6M Funding to Revolutionize Biological Engineering
(3:59): Ultragenyx's Drug Failure Sparks Stock Plunge, Reassessment of Angelman Syndrome Program
(6:03): 1990 IPCC Report Vindicated: Climate Change Predictions Hindered by Political Will, Not Science
(7:44): Study Unveils ATRX's Crucial Role in DNA Replication and Telomere Maintenance
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: WSOC TV